UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis

Hill, MR; Papafili, A; Booth, H; Lawson, P; Hubner, M; Beynon, H; Read, C; ... Laurent, GJ; + view all (2006) Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. AM J RESP CRIT CARE , 174 (8) 915 - 922. 10.1164/rccm.200512-1839OC.

Full text not available from this repository.

Abstract

Rationale: The majority of patients with sarcoidosis resolve their condition; however 5-10% of patients with sarcoidosis develop pulmonary fibrosis with poor prognosis. Prostaglandin-endoperoxide synthase 2 (PTGS2) is a key regulatory enzyme in the synthesis of the antifibrotic agent prostaglandin E-2 and is reduced in sarcoidosis lung. A promoter polymorphism in PTGS2, -765G > C, is reported to reduce its expression.Objectives: To investigate if - 765G > C is associated with susceptibility to, and poorer outcome within, sarcoidosis and to examine a possible mechanism by which -765G > C reduces PTGS2 expression.Methods: We used a case-control design study and genotyped -765G > C in awhite British population of 198 patients with sarcoidosis and 166 control subjects. Patients with sarcoidosis were classified before genotyping as having persistent or nonpersistent disease using clinical criteria that included chest radiography staging, need for treatment, lung function, and longitudinal follow-up. Electrophoretic mobility shift assays were used to identify changes in transcription factor binding caused by the -765G > C polymorphism.Results: Carriage of the -765C allele was strongly associated with susceptibility to sarcoidosis (odds ratio, 2.50; 95% confidence interval, 1.51-4.13; p = 0.006) and, within this disease, with poorer outcome (odds ratio, 3.11; 95% confidence interval, 1.35-7.13; p = 0.008). The association with sarcoldosis was replicated in a second Austrian population. Electrophoretic mobility shift assays revealed that the - 765C allele causes a loss of Sp1/Sp3 transcription factor binding and an increase in Egr-1 binding to the region.Conclusion: Our data suggest that the -765G > C polymorphism identifies individuals who are susceptible to sarcoldosis and, more importantly, at risk of pulmonary fibrotic disease. An altered Sp1/Sp3 binding to the - 765 region may contribute to the mechanism by which -765G > C reduces PTGS2 expression.

Type: Article
Title: Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis
DOI: 10.1164/rccm.200512-1839OC
Keywords: cyclooxygenase-2, gene regulation, PTGS2, sarcoidosis, IDIOPATHIC PULMONARY-FIBROSIS, FIBROTIC LUNG FIBROBLASTS, GROWTH-FACTOR-BETA, CYCLOOXYGENASE-2-DEFICIENT MICE, PROMOTER VARIANT, CONTROLLED-TRIAL, GENE-EXPRESSION, E-2 PRODUCTION, EPIDEMIOLOGY, ASSOCIATION
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Internal Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine
URI: http://discovery.ucl.ac.uk/id/eprint/8334
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item